321 related articles for article (PubMed ID: 20167005)
1. The injured cochlea as a target for inflammatory processes, initiation of cell death pathways and application of related otoprotectives strategies.
Abi-Hachem RN; Zine A; Van De Water TR
Recent Pat CNS Drug Discov; 2010 Jun; 5(2):147-63. PubMed ID: 20167005
[TBL] [Abstract][Full Text] [Related]
2. A peptide inhibitor of c-Jun N-terminal kinase protects against both aminoglycoside and acoustic trauma-induced auditory hair cell death and hearing loss.
Wang J; Van De Water TR; Bonny C; de Ribaupierre F; Puel JL; Zine A
J Neurosci; 2003 Sep; 23(24):8596-607. PubMed ID: 13679429
[TBL] [Abstract][Full Text] [Related]
3. Blocking c-Jun-N-terminal kinase signaling can prevent hearing loss induced by both electrode insertion trauma and neomycin ototoxicity.
Eshraghi AA; Wang J; Adil E; He J; Zine A; Bublik M; Bonny C; Puel JL; Balkany TJ; Van De Water TR
Hear Res; 2007 Apr; 226(1-2):168-77. PubMed ID: 17098385
[TBL] [Abstract][Full Text] [Related]
4. Blocking pro-cell-death signal pathways to conserve hearing.
Dinh CT; Van De Water TR
Audiol Neurootol; 2009; 14(6):383-92. PubMed ID: 19923808
[TBL] [Abstract][Full Text] [Related]
5. Ablation of mixed lineage kinase 3 (Mlk3) does not inhibit ototoxicity induced by acoustic trauma or aminoglycoside exposure.
Polesskaya O; Cunningham LL; Francis SP; Luebke AE; Zhu X; Collins D; Vasilyeva ON; Sahler J; Desmet EA; Gelbard HA; Maggirwar SB; Walton JP; Frisina RD; Dewhurst S
Hear Res; 2010 Dec; 270(1-2):21-7. PubMed ID: 20971179
[TBL] [Abstract][Full Text] [Related]
6. Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss.
Wang J; Ladrech S; Pujol R; Brabet P; Van De Water TR; Puel JL
Cancer Res; 2004 Dec; 64(24):9217-24. PubMed ID: 15604295
[TBL] [Abstract][Full Text] [Related]
7. ASK1 is a novel molecular target for preventing aminoglycoside-induced hair cell death.
Ogier JM; Gao Y; Dunne EM; Wilson MA; Ranganathan SC; Tesch GH; Nikolic Paterson DJ; Dabdoub A; Burt RA; Nayagam BA; Lockhart PJ
J Mol Med (Berl); 2022 May; 100(5):797-813. PubMed ID: 35471608
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea.
Kaur T; Borse V; Sheth S; Sheehan K; Ghosh S; Tupal S; Jajoo S; Mukherjea D; Rybak LP; Ramkumar V
J Neurosci; 2016 Apr; 36(14):3962-77. PubMed ID: 27053204
[TBL] [Abstract][Full Text] [Related]
9. A novel organ of corti explant model for the study of cochlear implantation trauma.
Bas E; Gupta C; Van De Water TR
Anat Rec (Hoboken); 2012 Nov; 295(11):1944-56. PubMed ID: 23044812
[TBL] [Abstract][Full Text] [Related]
10. D-JNKI-1 treatment prevents the progression of hearing loss in a model of cochlear implantation trauma.
Eshraghi AA; He J; Mou CH; Polak M; Zine A; Bonny C; Balkany TJ; Van De Water TR
Otol Neurotol; 2006 Jun; 27(4):504-11. PubMed ID: 16791042
[TBL] [Abstract][Full Text] [Related]
11. Hsp70 inhibits aminoglycoside-induced hearing loss and cochlear hair cell death.
Taleb M; Brandon CS; Lee FS; Harris KC; Dillmann WH; Cunningham LL
Cell Stress Chaperones; 2009 Jul; 14(4):427-37. PubMed ID: 19145477
[TBL] [Abstract][Full Text] [Related]
12. Conservation of hearing and protection of hair cells in cochlear implant patients' with residual hearing.
Bas E; Dinh CT; Garnham C; Polak M; Van de Water TR
Anat Rec (Hoboken); 2012 Nov; 295(11):1909-27. PubMed ID: 23044907
[TBL] [Abstract][Full Text] [Related]
13. Allicin protects auditory hair cells and spiral ganglion neurons from cisplatin - Induced apoptosis.
Wu X; Li X; Song Y; Li H; Bai X; Liu W; Han Y; Xu L; Li J; Zhang D; Wang H; Fan Z
Neuropharmacology; 2017 Apr; 116():429-440. PubMed ID: 28062185
[TBL] [Abstract][Full Text] [Related]
14. Arrest of apoptosis in auditory neurons: implications for sensorineural preservation in cochlear implantation.
Scarpidis U; Madnani D; Shoemaker C; Fletcher CH; Kojima K; Eshraghi AA; Staecker H; Lefebvre P; Malgrange B; Balkany TJ; Van De Water TR
Otol Neurotol; 2003 May; 24(3):409-17. PubMed ID: 12806293
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of programmed cell death signaling in hair cells and support cells post-electrode insertion trauma.
Eshraghi AA; Lang DM; Roell J; Van De Water TR; Garnham C; Rodrigues H; Guardiola M; Gupta C; Mittal J
Acta Otolaryngol; 2015 Apr; 135(4):328-34. PubMed ID: 25761716
[TBL] [Abstract][Full Text] [Related]
16. JNK signaling in neomycin-induced vestibular hair cell death.
Sugahara K; Rubel EW; Cunningham LL
Hear Res; 2006 Nov; 221(1-2):128-35. PubMed ID: 17005344
[TBL] [Abstract][Full Text] [Related]
17. Preclinical and clinical otoprotective applications of cell-penetrating peptide D-JNKI-1 (AM-111).
Eshraghi AA; Aranke M; Salvi R; Ding D; Coleman JKM; Ocak E; Mittal R; Meyer T
Hear Res; 2018 Oct; 368():86-91. PubMed ID: 29573879
[TBL] [Abstract][Full Text] [Related]
18. Cochlear implantation trauma and noise-induced hearing loss: Apoptosis and therapeutic strategies.
Eshraghi AA; Van de Water TR
Anat Rec A Discov Mol Cell Evol Biol; 2006 Apr; 288(4):473-81. PubMed ID: 16550592
[TBL] [Abstract][Full Text] [Related]
19. New pharmacological strategies to restore hearing and treat tinnitus.
Guitton MJ; Wang J; Puel JL
Acta Otolaryngol; 2004 May; 124(4):411-5. PubMed ID: 15224865
[TBL] [Abstract][Full Text] [Related]
20. Blockade of c-Jun N-terminal kinase pathway attenuates gentamicin-induced cochlear and vestibular hair cell death.
Ylikoski J; Xing-Qun L; Virkkala J; Pirvola U
Hear Res; 2002 Apr; 166(1-2):33-43. PubMed ID: 12062756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
